Kalofonos Isabelinsider trades
In SEC Form 4 filings, Kalofonos Isabel is listed as Chief Commercial Officer of CG Oncology, Inc. (CGON) and Chief Commercial Officer of Crinetics Pharmaceuticals, Inc. (CRNX). Kalofonos Isabel reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 19.
Companies and roles
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-01
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| CGONCG Oncology, Inc. | Oct 15 | Oct 19 | A · derivative | 92,000 | $61.86 | $5,691,120 | 92,000 | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D | 1,669 | $85.00 | $141,865 | 34,000 | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D | 34,000 | $85.00 | $2,890,000 | not reported | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D · derivative | 97,500 | $44.41 | $4,329,975 | not reported | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D · derivative | 55,000 | $41.21 | $2,266,550 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.